| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ABBV | Common Stock, $0.01 par value | Options Exercise | $3.11M | +52.9K | +21.67% | $58.88 | 297K | Feb 21, 2024 | Direct | |
| transaction | ABBV | Common Stock, $0.01 par value | Sale | -$9.18M | -52.9K | -17.81% | $173.71 | 244K | Feb 21, 2024 | Direct | F1 |
| holding | ABBV | Common Stock, $0.01 par value | 2.32K | Feb 21, 2024 | Profit sharing trust | F2 | |||||
| holding | ABBV | Common Stock, $0.01 par value | 3.87K | Feb 21, 2024 | By spouse | F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ABBV | Option (Right to Buy) | Options Exercise | -$3.11M | -52.9K | -100% | $58.88 | 0 | Feb 21, 2024 | Common Stock | 52.9K | $58.88 | Direct | F4 |
| Id | Content |
|---|---|
| F1 | The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $173.51 to $174.03, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F2 | Balance in AbbVie Savings program as of January 31, 2024. |
| F3 | The reporting person disclaims beneficial ownership of all securities held by her spouse. |
| F4 | Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. |